Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Inv. presentation
Avidity Biosciences, Inc. (RNA) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Other Events  Interactive Data
08/08/2023 8-K Quarterly results
Docs: "Avidity Biosciences Reports Second Quarter 2023 Financial Results and Recent Highlights Advancing three clinical development programs – DM1, DMD, FSHD - with data anticipated from each program over the next 12 months"
07/10/2023 8-K Regulation FD Disclosure, Other Events  Interactive Data
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/17/2023 8-K Other Events  Interactive Data
05/09/2023 8-K Quarterly results
Docs: "Avidity Biosciences Reports First Quarter 2023 Financial Results and Recent Highlights Positive Topline Data from AOC 1001 Phase 1/2 MARINA™ Trial Demonstrated Functional Improvement, Disease Modification and Favorable Safety and Tolerability Profile in People Living with Myotonic Dystrophy Type 1"
04/27/2023 8-K Quarterly results
03/30/2023 8-K Quarterly results
02/28/2023 8-K Quarterly results
Docs: "Avidity Biosciences Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Highlights"
02/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/16/2022 8-K Quarterly results
12/14/2022 8-K Quarterly results
12/05/2022 8-K Quarterly results
11/08/2022 8-K Quarterly results
10/13/2022 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
09/27/2022 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
08/09/2022 8-K Quarterly results
Docs: "Avidity Biosciences Reports Second Quarter 2022 Financial Results and Recent Highlights Company remains on track to have three programs in the clinic by the end of this year"
06/17/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
03/01/2022 8-K Quarterly results
Docs: "Avidity Biosciences Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Highlights"
01/06/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/09/2021 8-K Quarterly results
11/09/2021 8-K Quarterly results
Docs: "Avidity Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights Initiated the Phase 1/2 MARINA TM trial of AOC 1001, marking the first AOC in clinical development On track to have three clinical programs by the end of 2022"
09/01/2021 8-K Quarterly results
08/25/2021 8-K Quarterly results
08/09/2021 8-K Quarterly results
Docs: "Avidity Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights"
08/04/2021 8-K Quarterly results
08/02/2021 8-K Quarterly results
08/02/2021 8-K Investor presentation
Docs: "Slide Presentation"
07/02/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Sales Agreement, between Avidity Biosciences, Inc. and Cowen and Company, LLC"
06/17/2021 8-K Quarterly results
05/19/2021 8-K Quarterly results
05/12/2021 8-K Quarterly results
03/15/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy